AKT1 and polycystic ovary syndrome: This drug can inhibit GCs cell autophagy and promote follicle development to alleviate ovulation disorders in PCOS combined with IR rats, which is associated with the activation of PI3K/AKT/mTOR signaling pathway by the drug (74).